Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2017159560
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2017159560
Title / Product Name
VERMEIDUNG UNERWÜNSCHTER NEBENWIRKUNGEN DURCH CD3-SPEZIFISCHE BINDUNGSDOMÄNEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2017159560
EP Publication Number
3228315
E-Number
1337490
Language
EN
PCT Number
-
Publication Date
11.10.2017 A
25.11.2020 B1
Registration Date
25.11.2020
AT Publication Date
15.12.2020
Application Date
27.10.2011
Registration Number
-
Priorities
10.11.2010
US
412229 P
IPC
A61K 31/573 20060101AFI20170801BHEP
Maximum Duration of Protection
27.10.2031
Owner
Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 München
DE
Representative
No representatives present
Inventor
ZUGMAIER, Gerhard
c/o Amgen Research (Munich) GmbH Staffelseestr. 2
81477 Muenchen
DE
NAGORSEN, Dirk
c/o Amgen Research (Munich) GmbH Staffelseestr. 2
81477 Muenchen
DE
SCHEELE, Juergen
c/o Amgen Research (Munich) GmbH Staffelseestr. 2
81477 Muenchen
DE
see.ip - Details for VERMEIDUNG UNERWÜNSCHTER NEBENWIRKUNGEN DURCH CD3-SPEZIFISCHE BINDUNGSDOMÄNEN